JP2013181001A - Hyaluronic acid composition and skin care preparation including the same - Google Patents
Hyaluronic acid composition and skin care preparation including the same Download PDFInfo
- Publication number
- JP2013181001A JP2013181001A JP2012046575A JP2012046575A JP2013181001A JP 2013181001 A JP2013181001 A JP 2013181001A JP 2012046575 A JP2012046575 A JP 2012046575A JP 2012046575 A JP2012046575 A JP 2012046575A JP 2013181001 A JP2013181001 A JP 2013181001A
- Authority
- JP
- Japan
- Prior art keywords
- hyaluronic acid
- salt
- skin
- acid composition
- molecular weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920002674 hyaluronan Polymers 0.000 title claims abstract description 179
- 229960003160 hyaluronic acid Drugs 0.000 title claims abstract description 179
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title claims abstract description 178
- 239000000203 mixture Substances 0.000 title claims abstract description 98
- 238000002360 preparation method Methods 0.000 title claims abstract description 32
- 150000003839 salts Chemical class 0.000 claims abstract description 63
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000007864 aqueous solution Substances 0.000 claims abstract description 11
- 239000002244 precipitate Substances 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims description 15
- 230000003020 moisturizing effect Effects 0.000 abstract description 21
- 239000000243 solution Substances 0.000 abstract description 10
- 238000006243 chemical reaction Methods 0.000 abstract description 4
- 239000002253 acid Substances 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 77
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 20
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 17
- -1 hyaluronic acid oligosaccharide Chemical class 0.000 description 17
- 239000003795 chemical substances by application Substances 0.000 description 13
- 239000012085 test solution Substances 0.000 description 13
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 12
- 239000002994 raw material Substances 0.000 description 11
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 238000009472 formulation Methods 0.000 description 10
- 239000006210 lotion Substances 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 10
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 10
- 229960002216 methylparaben Drugs 0.000 description 10
- 239000002304 perfume Substances 0.000 description 10
- 239000008213 purified water Substances 0.000 description 10
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 10
- 239000000284 extract Substances 0.000 description 9
- 108090000765 processed proteins & peptides Proteins 0.000 description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 6
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 6
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 6
- 229960003415 propylparaben Drugs 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 229940058015 1,3-butylene glycol Drugs 0.000 description 5
- 229920002385 Sodium hyaluronate Polymers 0.000 description 5
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 description 5
- 229960000541 cetyl alcohol Drugs 0.000 description 5
- 238000010908 decantation Methods 0.000 description 5
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 229940010747 sodium hyaluronate Drugs 0.000 description 5
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 5
- 229940032094 squalane Drugs 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 229940008099 dimethicone Drugs 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 229960005323 phenoxyethanol Drugs 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 102000011782 Keratins Human genes 0.000 description 3
- 108010076876 Keratins Proteins 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 239000001587 sorbitan monostearate Substances 0.000 description 3
- 235000011076 sorbitan monostearate Nutrition 0.000 description 3
- 229940035048 sorbitan monostearate Drugs 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 3
- 229940099259 vaseline Drugs 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- 229940043375 1,5-pentanediol Drugs 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 108010039491 Ricin Proteins 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 229920006317 cationic polymer Polymers 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- 229940110767 coenzyme Q10 Drugs 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000007934 lip balm Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000004137 magnesium phosphate Substances 0.000 description 2
- 229960002261 magnesium phosphate Drugs 0.000 description 2
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 2
- 235000010994 magnesium phosphates Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000002952 polymeric resin Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 229950011392 sorbitan stearate Drugs 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 2
- PUVAFTRIIUSGLK-UHFFFAOYSA-M trimethyl(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1CO1 PUVAFTRIIUSGLK-UHFFFAOYSA-M 0.000 description 2
- 210000003954 umbilical cord Anatomy 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- CRBBOOXGHMTWOC-NPDDRXJXSA-N 1,4-Anhydro-6-O-dodecanoyl-2,3-bis-O-(2-hydroxyethyl)-D-glucitol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](OCCO)[C@H]1OCCO CRBBOOXGHMTWOC-NPDDRXJXSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- YICVJSOYNBZJAK-UHFFFAOYSA-N 14-methylpentadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C YICVJSOYNBZJAK-UHFFFAOYSA-N 0.000 description 1
- FUWVMBCPMRAWPG-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-hydroxyoctadecanoate Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)OCC(O)CO FUWVMBCPMRAWPG-UHFFFAOYSA-N 0.000 description 1
- CLAHOZSYMRNIPY-UHFFFAOYSA-N 2-hydroxyethylurea Chemical compound NC(=O)NCCO CLAHOZSYMRNIPY-UHFFFAOYSA-N 0.000 description 1
- CNXZMGRWEYQCOQ-UHFFFAOYSA-N 2-methoxy-3-phenylprop-2-enoic acid Chemical class COC(C(O)=O)=CC1=CC=CC=C1 CNXZMGRWEYQCOQ-UHFFFAOYSA-N 0.000 description 1
- HMFKFHLTUCJZJO-UHFFFAOYSA-N 2-{2-[3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-(2-hydroxyethoxy)ethoxy}ethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOCC(OCCO)C1OCC(OCCO)C1OCCO HMFKFHLTUCJZJO-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical class NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- FXALIOUHXMVTMJ-UHFFFAOYSA-N CCCCCCCCCCCC([Na])=O Chemical compound CCCCCCCCCCCC([Na])=O FXALIOUHXMVTMJ-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical class CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DATAGRPVKZEWHA-UHFFFAOYSA-N L-gamma-glutamyl-n-ethylamine Natural products CCNC(=O)CCC(N)C(O)=O DATAGRPVKZEWHA-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229920002387 Phytoglycogen Polymers 0.000 description 1
- 229920000289 Polyquaternium Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 238000010162 Tukey test Methods 0.000 description 1
- YFCGDEUVHLPRCZ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C YFCGDEUVHLPRCZ-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229920006319 cationized starch Polymers 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 239000008294 cold cream Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 229940062933 dimethylsilanol hyaluronate Drugs 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 229940012466 egg shell membrane Drugs 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940009626 etidronate Drugs 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- BYSGBSNPRWKUQH-UJDJLXLFSA-N glycogen Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)O1 BYSGBSNPRWKUQH-UJDJLXLFSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940031575 hydroxyethyl urea Drugs 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940078568 isocetyl myristate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- WWVIUVHFPSALDO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C WWVIUVHFPSALDO-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 229940045944 sodium lauroyl glutamate Drugs 0.000 description 1
- IWIUXJGIDSGWDN-UQKRIMTDSA-M sodium;(2s)-2-(dodecanoylamino)pentanedioate;hydron Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O IWIUXJGIDSGWDN-UQKRIMTDSA-M 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 229940093609 tricaprylin Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
- OWVLYQRCCIEOPF-QHTZZOMLSA-L zinc;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound [Zn+2].[O-]C(=O)[C@@H]1CCC(=O)N1.[O-]C(=O)[C@@H]1CCC(=O)N1 OWVLYQRCCIEOPF-QHTZZOMLSA-L 0.000 description 1
- LTVDFSLWFKLJDQ-UHFFFAOYSA-N α-tocopherolquinone Chemical group CC(C)CCCC(C)CCCC(C)CCCC(C)(O)CCC1=C(C)C(=O)C(C)=C(C)C1=O LTVDFSLWFKLJDQ-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、低分子ヒアルロン酸およびカチオン化ヒアルロン酸を含有するヒアルロン酸組成物、これを用いた皮膚外用剤、およびこれを使用する皮膚水分量の増加方法に関する。 The present invention relates to a hyaluronic acid composition containing low-molecular hyaluronic acid and cationized hyaluronic acid, a skin external preparation using the composition, and a method for increasing the amount of skin moisture using the hyaluronic acid composition.
ヒアルロン酸は、鶏冠、さい帯、皮膚、軟骨、硝子体、関節液などの生体組織中に広く分布するムコ多糖であり、その高い保湿機能により、化粧料の成分として広く利用されている。 Hyaluronic acid is a mucopolysaccharide widely distributed in living tissues such as chicken crown, umbilical cord, skin, cartilage, vitreous body and joint fluid, and is widely used as a component of cosmetics due to its high moisturizing function.
しかしながら、一般的に皮膚外用剤として使用されているヒアルロン酸は高分子の多糖類であるため、生体内に吸収されにくい。例えば、ヒアルロン酸を皮膚に塗布することにより、皮膚からの水分の蒸散を防ぐことはできるが、ヒアルロン酸は高分子(平均分子量:50万〜200万)であるため、皮膚組織へ浸透しにくく、大部分が皮膚の表面に留まるのみである。したがって、洗顔や入浴等により皮膚表面のヒアルロン酸が洗い流されると、皮膚の保湿効果が持続しにくい。 However, hyaluronic acid, which is generally used as an external preparation for skin, is a high-molecular polysaccharide and is therefore difficult to be absorbed in the living body. For example, by applying hyaluronic acid to the skin, it is possible to prevent moisture from evaporating from the skin. However, since hyaluronic acid is a polymer (average molecular weight: 500,000 to 2,000,000), it hardly penetrates into skin tissue. Most of it only stays on the surface of the skin. Therefore, if hyaluronic acid on the skin surface is washed away by face washing or bathing, the skin moisturizing effect is difficult to sustain.
そこで、皮膚に浸透しやすいヒアルロン酸として、重量平均分子量70万以上150万以下のヒアルロン酸およびヒアルロン酸オリゴ糖を含有する組成物が記載されている(特許文献1)。 Therefore, a composition containing hyaluronic acid and hyaluronic acid oligosaccharide having a weight average molecular weight of 700,000 to 1.5 million is described as hyaluronic acid that easily penetrates into the skin (Patent Document 1).
しかしながら、特許文献1に記載された組成物の場合、表皮における角質間隙からの浸透性を高めるために開発されたものではあるが、皮膚の保湿効果は十分なものとは言い難かった。 However, in the case of the composition described in Patent Document 1, it was developed to increase the permeability from the keratin gap in the epidermis, but it was difficult to say that the skin moisturizing effect was sufficient.
本発明の目的は、皮膚について高い保湿効果を有するヒアルロン酸組成物、これを含む皮膚外用剤、およびこれを使用する皮膚水分量の増加方法を提供することである。 An object of the present invention is to provide a hyaluronic acid composition having a high moisturizing effect on the skin, a skin external preparation containing the composition, and a method for increasing the amount of skin moisture using the composition.
本発明は、
(1)平均分子量が100,000以下の低分子ヒアルロン酸および/またはその塩とカチオン化ヒアルロン酸および/またはその塩の含有割合が質量比で5:95〜80:20であるヒアルロン酸組成物であって、
前記低分子ヒアルロン酸および/またはその塩と前記カチオン化ヒアルロン酸および/またはその塩をヒアルロン酸換算で合計1質量%となるように調製した前記ヒアルロン酸組成物の水溶液が、沈殿物を生じることなく水に溶解していることを特徴とするヒアルロン酸組成物、
(2)前記低分子ヒアルロン酸および/またはその塩の平均分子量が400〜50,000である(1)に記載のヒアルロン酸組成物、
(3)平均分子量が100,000超のヒアルロン酸および/またはその塩をさらに含有する(1)または(2)に記載の組成物、
(4)(1)ないし(3)のいずれか1項に記載のヒアルロン酸組成物を含有する皮膚外用剤、
(5)(1)ないし(3)のいずれか1項に記載のヒアルロン酸組成物を使用する皮膚水分量の増加方法、
である。
The present invention
(1) Hyaluronic acid composition in which the content ratio of low molecular weight hyaluronic acid and / or salt thereof and cationized hyaluronic acid and / or salt thereof having an average molecular weight of 100,000 or less is 5:95 to 80:20 by mass ratio Because
An aqueous solution of the hyaluronic acid composition prepared by adding the low molecular weight hyaluronic acid and / or salt thereof and the cationized hyaluronic acid and / or salt thereof to a total amount of 1% by mass in terms of hyaluronic acid produces a precipitate. Hyaluronic acid composition, characterized in that it is dissolved in water,
(2) The hyaluronic acid composition according to (1), wherein the low molecular weight hyaluronic acid and / or salt thereof has an average molecular weight of 400 to 50,000,
(3) The composition according to (1) or (2), further comprising hyaluronic acid having an average molecular weight of more than 100,000 and / or a salt thereof,
(4) a skin external preparation containing the hyaluronic acid composition according to any one of (1) to (3),
(5) A method for increasing the amount of skin moisture using the hyaluronic acid composition according to any one of (1) to (3),
It is.
上記ヒアルロン酸組成物を皮膚に塗布した場合、皮膚の水分量を高めることができるため、皮膚を瑞々しい状態に保つことができる。
また、上記ヒアルロン酸組成物は、通常の平均分子量が100,000超のヒアルロン酸が有する保湿効果をさらに高めることができる。そのため、保湿剤として当該平均分子量が100,000超ヒアルロン酸を含有する皮膚外用剤に上記ヒアルロン酸組成物を含有させることで、保湿剤の配合量を増やすことなく、保湿効果を高めることが可能である。
When the hyaluronic acid composition is applied to the skin, the moisture content of the skin can be increased, so that the skin can be kept fresh.
Moreover, the said hyaluronic acid composition can further enhance the moisturizing effect of a normal hyaluronic acid having an average molecular weight of over 100,000. Therefore, it is possible to enhance the moisturizing effect without increasing the blending amount of the moisturizing agent by adding the hyaluronic acid composition to the skin external preparation containing the hyaluronic acid having an average molecular weight exceeding 100,000 as the moisturizing agent. It is.
以下、本発明の一実施形態に係る低分子ヒアルロン酸および/またはその塩とカチオン化ヒアルロン酸および/またはその塩を含有するヒアルロン酸組成物、およびこれを含む皮膚外用剤について詳細に説明する。なお、本発明において「%」は「質量%」、「部」は質量部を意味する。 Hereinafter, a hyaluronic acid composition containing a low molecular weight hyaluronic acid and / or salt thereof and a cationized hyaluronic acid and / or salt thereof according to an embodiment of the present invention, and a skin external preparation containing the same will be described in detail. In the present invention, “%” means “mass%” and “part” means mass part.
1.ヒアルロン酸組成物
1.1.低分子ヒアルロン酸および/またはその塩
本実施形態に係るヒアルロン酸組成物は、平均分子量が100,000以下の低分子ヒアルロン酸および/またはその塩を含む。
上記低分子ヒアルロン酸および/またはその塩の平均分子量は、皮膚水分量の増加効果が優れている点で、400〜50,000であるのが好ましく、1,000〜30,000であるのがより好ましい。
1. Hyaluronic acid composition 1.1. Low molecular weight hyaluronic acid and / or salt thereof The hyaluronic acid composition according to the present embodiment includes low molecular weight hyaluronic acid and / or a salt thereof having an average molecular weight of 100,000 or less.
The average molecular weight of the low molecular weight hyaluronic acid and / or salt thereof is preferably 400 to 50,000, more preferably 1,000 to 30,000, from the viewpoint of excellent effect of increasing skin moisture. More preferred.
1.1.1.平均分子量
本発明において、ヒアルロン酸および/またはその塩の平均分子量は、以下の方法にて測定された値である。
1.1.1. Average molecular weight In the present invention, the average molecular weight of hyaluronic acid and / or a salt thereof is a value measured by the following method.
即ち、約0.05gのヒアルロン酸および/またはその塩(本品)を精密に量り、0.2mol/L濃度の塩化ナトリウム溶液に溶かし、正確に100mLとした溶液およびこの溶液8mL、12mL並びに16mLを正確に量り、それぞれに0.2mol/L濃度の塩化ナトリウム溶液を加えて正確に20mLとした溶液を試料溶液とする。この試料溶液および0.2mol/L濃度の塩化ナトリウム溶液につき、日本薬局方(第十五改正)一般試験法の粘度測定法(第1法
毛細管粘度計法)により30.0±0.1℃で比粘度を測定し(式(A))、各濃度における還元粘度を算出する(式(B))。還元粘度を縦軸に、本品の換算した乾燥物に対する濃度(g/100mL)を横軸にとってグラフを描き、各点を結ぶ直線と縦軸との交点から極限粘度を求める。ここで求められた極限粘度をLaurentの式(式(C))に代入し、平均分子量を算出する(T.C. Laurent, M. Ryan, A. Pietruszkiewicz,:B.B.A., 42, 476-485(1960))。
That is, about 0.05 g of hyaluronic acid and / or a salt thereof (this product) was precisely weighed and dissolved in a 0.2 mol / L sodium chloride solution to make exactly 100 mL, and this solution 8 mL, 12 mL and 16 mL Is accurately measured, and a 0.2 mol / L sodium chloride solution is added to each to make exactly 20 mL. This sample solution and a 0.2 mol / L sodium chloride solution were measured at 30.0 ± 0.1 ° C. according to the Japanese Pharmacopoeia (Fifteenth revision) general test method viscosity measurement method (first method capillary viscometer method). The specific viscosity is measured by (Equation (A)), and the reduced viscosity at each concentration is calculated (Equation (B)). A graph is drawn with the reduced viscosity on the vertical axis and the concentration (g / 100 mL) of the product converted to dry matter on the horizontal axis, and the intrinsic viscosity is determined from the intersection of the straight line connecting the points and the vertical axis. Substituting the intrinsic viscosity obtained here into Laurent's formula (formula (C)) to calculate the average molecular weight (TC Laurent, M. Ryan, A. Pietruszkiewicz,: BBA, 42, 476-485 (1960)) .
(式A)
比粘度 = {試料溶液の所要流下秒数)/(0.2mol/L塩化ナトリウム溶液の所要流下秒数)}−1
(Formula A)
Specific viscosity = {required flow time of sample solution) / (required flow time of 0.2 mol / L sodium chloride solution)} − 1
(式B)
還元粘度(dL/g)=
比粘度/(本品の換算した乾燥物に対する濃度g/100mL))
(Formula B)
Reduced viscosity (dL / g) =
Specific viscosity / (Concentration g / 100mL with respect to the dried product converted to this product))
(式C)
極限粘度(dL/g)=3.6×10−4M0.78
M:平均分子量
(Formula C)
Intrinsic viscosity (dL / g) = 3.6 × 10 −4 M 0.78
M: average molecular weight
1.1.2.低分子ヒアルロン酸および/またはその塩の製造方法
上記低分子ヒアルロン酸および/またはその塩の製造に使用される原料ヒアルロン酸および/またはその塩は、動物等の生体組織(例えば、鶏冠、さい帯、皮膚、関節液など)から抽出されたものでもよく、または、微生物、動物細胞もしくは植物細胞を培養して得られたもの(例えばストレプトコッカス属の細菌等を用いた発酵法)、化学的または酵素的に合成されたものなどを使用することができる。
1.1.2. Method for producing low molecular hyaluronic acid and / or salt thereof The raw material hyaluronic acid and / or salt thereof used in the production of the low molecular hyaluronic acid and / or salt thereof is a living tissue such as an animal (for example, chicken crown, umbilical cord, It may be extracted from skin, synovial fluid, etc., or obtained by culturing microorganisms, animal cells or plant cells (eg fermentation using bacteria of the genus Streptococcus), chemical or enzymatic Those synthesized in the above can be used.
上記低分子ヒアルロン酸および/またはその塩を製造する方法は、特に限定されるわけではなく、原料ヒアルロン酸から公知の加水分解方法を用いて行うことができる。例えば、酵素等を用いてヒアルロン酸を低分子化する方法、酸またはアルカリ条件下で低分子化する方法などが挙げられる。中でも、得られた低分子ヒアルロン酸および/またはその塩の分離精製が容易であって、低コストで収率良く製造することが出来る点から、酸性含水媒体中にヒアルロン酸および/またはその塩を分散させることにより製造するのが好ましい。 The method for producing the low-molecular hyaluronic acid and / or salt thereof is not particularly limited, and can be carried out using a known hydrolysis method from the raw material hyaluronic acid. For example, a method of reducing the molecular weight of hyaluronic acid using an enzyme or the like, a method of reducing the molecular weight under acid or alkaline conditions, and the like can be mentioned. Among them, hyaluronic acid and / or a salt thereof is contained in an acidic water-containing medium because it is easy to separate and purify the obtained low-molecular hyaluronic acid and / or a salt thereof, and can be produced at a low cost with a high yield. It is preferable to manufacture by dispersing.
上記低分子ヒアルロン酸および/またはその塩としては、精製物、具体的にはヒアルロン酸および/またはその塩の純度が90%以上のものが好ましい。純度が90%未満の低分子ヒアルロン酸および/またはその塩を用いた場合、低分子ヒアルロン酸および/またはその塩とカチオン化ヒアルロン酸および/またはその塩を含有するヒアルロン酸組成物の保湿効果が低下する場合があるため好ましくない。 The low molecular weight hyaluronic acid and / or salt thereof is preferably a purified product, specifically, hyaluronic acid and / or salt thereof having a purity of 90% or more. When low molecular hyaluronic acid and / or a salt thereof having a purity of less than 90% is used, the moisturizing effect of the hyaluronic acid composition containing low molecular hyaluronic acid and / or a salt thereof and cationized hyaluronic acid and / or a salt thereof is improved. Since it may decrease, it is not preferable.
1.2.カチオン化ヒアルロン酸および/またはその塩
本実施形態に係るヒアルロン酸組成物は、カチオン化ヒアルロン酸および/またはその塩を含む。
1.2. Cationized hyaluronic acid and / or salt thereof The hyaluronic acid composition according to this embodiment includes cationized hyaluronic acid and / or a salt thereof.
1.2.1.カチオン化ヒアルロン酸および/またはその塩の製造方法
上記カチオン化ヒアルロン酸および/またはその塩の製造に使用される原料ヒアルロン酸および/またはその塩は、平均分子量が、使用後の保湿感、および皮膚外用剤への配合のしやすさの点で、800〜250万であるのがより好ましく、5万〜200万であるのがさらに好ましい。
1.2.1. Method for producing cationized hyaluronic acid and / or salt thereof The raw material hyaluronic acid and / or salt thereof used for producing the cationized hyaluronic acid and / or salt thereof has an average molecular weight, a moisturizing feeling after use, and skin In terms of ease of blending into an external preparation, it is more preferably from 800 to 2,500,000, and even more preferably from 50,000 to 2,000,000.
本発明の皮膚外用剤に使用されるカチオン化ヒアルロン酸および/またはその塩は、原料ヒアルロン酸および/またはその塩を塩基性含水媒体中でカチオン化剤と反応させる工程によって得られる。上記方法によれば、例えば、原料ヒアルロン酸および/またはその塩を水に溶解させてカチオン化剤と反応させる場合と比較して、製造工程の効率を高めることができる。 The cationized hyaluronic acid and / or salt thereof used in the external preparation for skin of the present invention can be obtained by reacting the raw material hyaluronic acid and / or salt thereof with a cationizing agent in a basic water-containing medium. According to the said method, the efficiency of a manufacturing process can be improved compared with the case where the raw material hyaluronic acid and / or its salt are dissolved in water, and made to react with a cationizing agent, for example.
上記カチオン化ヒアルロン酸および/またはその塩の製造方法において、原料ヒアルロン酸および/またはその塩を塩基性含水媒体中でカチオン化剤と反応させる工程では、原料ヒアルロン酸および/またはその塩は、塩基性含水媒体中に分散させた状態でカチオン化剤と反応させることが好ましい。ここで、反応条件(時間、温度等)を調製することにより、カチオン化の度合いを調製することができる。 In the method for producing cationized hyaluronic acid and / or salt thereof, in the step of reacting raw material hyaluronic acid and / or salt thereof with a cationizing agent in a basic water-containing medium, the raw material hyaluronic acid and / or salt thereof is a base. It is preferable to make it react with a cationizing agent in the state disperse | distributed in the property water-containing medium. Here, the degree of cationization can be adjusted by adjusting the reaction conditions (time, temperature, etc.).
使用可能なカチオン化剤としては、第四級アンモニウム含有基を含有するカチオン化剤が好ましい。例えば、2,3−エポキシプロピルトリアルキルアンモニウムハライド(グリシジルトリアルキルアンモニウム塩)および3−ハロゲノ−2−ヒドロキシプロピルトリアルキルアンモニウムハライド等の第四級アンモニウム基を含有するカチオン化剤が挙げられる。かかるカチオン化剤は単独でも、あるいは二種以上を組み合わせて使用してもよい。なかでも、カチオン化剤は、3−クロロ−2−ヒドロキシプロピルトリメチルアンモニウムクロリドおよびグリシジルトリメチルアンモニウムクロリドもしくはいずれか一方であることが好ましい。 As a usable cationizing agent, a cationizing agent containing a quaternary ammonium-containing group is preferable. Examples thereof include cationizing agents containing a quaternary ammonium group such as 2,3-epoxypropyltrialkylammonium halide (glycidyltrialkylammonium salt) and 3-halogeno-2-hydroxypropyltrialkylammonium halide. Such cationizing agents may be used alone or in combination of two or more. Among these, the cationizing agent is preferably 3-chloro-2-hydroxypropyltrimethylammonium chloride and / or glycidyltrimethylammonium chloride.
1.3.低分子ヒアルロン酸および/またはその塩とカチオン化ヒアルロン酸および/またはその塩の含有割合
本実施形態に係るヒアルロン酸組成物は、低分子ヒアルロン酸および/またはその塩とカチオン化ヒアルロン酸および/またはその塩の含有割合が質量比で5:95〜80:20、好ましくは10:90〜75:25、より好ましくは20:80〜40:60である。
本実施形態に係るヒアルロン酸組成物は、低分子ヒアルロン酸および/またはその塩とカチオン化ヒアルロン酸および/またはその塩の含有割合が上記質量比であることにより、皮膚中の水分量を高めることができる。
1.3. Content ratio of low molecular hyaluronic acid and / or salt thereof and cationized hyaluronic acid and / or salt thereof The hyaluronic acid composition according to the present embodiment comprises low molecular hyaluronic acid and / or salt thereof and cationized hyaluronic acid and / or The content ratio of the salt is 5:95 to 80:20, preferably 10:90 to 75:25, and more preferably 20:80 to 40:60 by mass ratio.
The hyaluronic acid composition according to the present embodiment increases the moisture content in the skin when the content ratio of the low-molecular hyaluronic acid and / or salt thereof and the cationized hyaluronic acid and / or salt thereof is the above-described mass ratio. Can do.
本実施形態に係るヒアルロン酸組成物の製造方法は、ヒアルロン酸および/またはその塩とカチオン化ヒアルロン酸および/またはその塩を含む組成物を得ることができる方法であれば、特に限定されるものではない。例えば、ヒアルロン酸および/またはその塩を含有する溶液と、カチオン化ヒアルロン酸および/またはその塩を含有する溶液とを混合し、噴霧乾燥、凍結乾燥等により乾燥処理を施した後、必要に応じて粉砕を行う方法や、ヒアルロン酸および/またはその塩を含有する粉末と、カチオン化ヒアルロン酸および/またはその塩を含有する粉末とを粉体混合し、粉末状の組成物を得る方法等が挙げられる。
なお、本実施形態に係るヒアルロン酸組成物は、ヒアルロン酸および/またはその塩を含有する溶液と、カチオン化ヒアルロン酸および/またはその塩を含有する溶液とを混合して得ることもできるが、当該混合溶液は、沈殿物を生じることなくヒアルロン酸組成物が水に溶解しており、皮膚用外用剤に好適に用いることができる。
The method for producing a hyaluronic acid composition according to the present embodiment is particularly limited as long as it is a method capable of obtaining a composition containing hyaluronic acid and / or a salt thereof and cationized hyaluronic acid and / or a salt thereof. is not. For example, a solution containing hyaluronic acid and / or a salt thereof and a solution containing cationized hyaluronic acid and / or a salt thereof are mixed, dried by spray drying, freeze drying, etc. Pulverization, powder containing hyaluronic acid and / or salt thereof and powder containing cationized hyaluronic acid and / or salt thereof are mixed to obtain a powdery composition. Can be mentioned.
The hyaluronic acid composition according to the present embodiment can be obtained by mixing a solution containing hyaluronic acid and / or a salt thereof and a solution containing cationized hyaluronic acid and / or a salt thereof, In the mixed solution, the hyaluronic acid composition is dissolved in water without causing precipitation, and can be suitably used for an external preparation for skin.
2.皮膚外用剤
本実施形態に係る皮膚外用剤は、上記ヒアルロン酸組成物を含有する。例えば、本実施形態に係る皮膚外用剤は、上記ヒアルロン酸組成物を保湿剤として含有することができる。また、本実施形態に係る皮膚外用剤は、上記ヒアルロン酸組成物を固形分換算で、通常0.001〜5%含有する。含有量が0.001%未満では、満足な保湿効果が得られないため、使用時の皮膚の乾燥を改善することができない恐れがある。含有量が5%を超えると、粘度が高くなりすぎ皮膚全体に伸ばしにくくなる恐れがある。
2. Skin external preparation The skin external preparation according to this embodiment contains the hyaluronic acid composition. For example, the external preparation for skin according to the present embodiment can contain the hyaluronic acid composition as a moisturizing agent. Moreover, the skin external preparation which concerns on this embodiment contains the said hyaluronic acid composition normally 0.001-5% in conversion of solid content. If the content is less than 0.001%, a satisfactory moisturizing effect cannot be obtained, so that there is a possibility that the drying of the skin during use cannot be improved. If the content exceeds 5%, the viscosity becomes too high and it may be difficult to extend the whole skin.
本実施形態に係る皮膚外用剤の態様は特に限定されないが、例えば、皮膚用化粧料が挙げられる。上記ヒアルロン酸組成物を皮膚用化粧料に使用することにより、皮膚水分量増加効果が高いため、皮膚に潤いを長期間付与し、皮膚のかさつき感を改善することができる。本実施形態に係る皮膚用化粧料の態様としては、例えば、洗顔料、洗浄料、化粧水(例えば、美白化粧水)、クリーム(例えば、バニシングクリーム、コールドクリーム)、乳液、美容液、パック(例えば、ゼリー状ピールオフタイプ、ペースト状拭き取りタイプ、粉末状洗い流しタイプ)、クレンジング、ファンデーション、口紅、リップクリーム、リップグロス、リップライナー、頬紅、シェービングローション、アフターサンローション、デオドラントローション、ボディローション(ハンドケアローション、フットケアローションを含む)、ボディオイル、石鹸、入浴剤が挙げられる。 Although the aspect of the skin external preparation which concerns on this embodiment is not specifically limited, For example, skin cosmetics are mentioned. By using the hyaluronic acid composition in a cosmetic for skin, the effect of increasing the amount of moisture in the skin is high, so that the skin can be moisturized for a long period of time, and the feeling of bulkiness of the skin can be improved. Examples of the cosmetic for skin according to the present embodiment include, for example, face wash, cleanser, lotion (for example, whitening lotion), cream (for example, vanishing cream, cold cream), milky lotion, cosmetic liquid, pack ( For example, jelly-type peel-off type, paste-type wipe-off type, powder-type wash-out type), cleansing, foundation, lipstick, lip balm, lip gloss, lip liner, blusher, shaving lotion, after sun lotion, deodorant lotion, body lotion (hand care lotion) Body oils, soaps, and bath additives.
本実施形態に係る皮膚用外用剤によれば、上記ヒアルロン酸組成物を含有することにより、皮膚の水分量を高くすることができるため、皮膚に潤いを与えることができる。 According to the external preparation for skin according to this embodiment, since the moisture content of the skin can be increased by containing the hyaluronic acid composition, the skin can be moisturized.
本実施形態に係る皮膚外用剤には、平均分子量が100,000超のヒアルロン酸および/またはその塩を含むことが好ましい。平均分子量が100,000超のヒアルロン酸は、保湿機能を有するが保湿効果の持続性は十分ではない。本発明に係るヒアルロン酸組成物を、平均分子量が100,000超のヒアルロン酸を含有する組成物に添加することにより、当該ヒアルロン酸の保湿機能を高め、保湿効果を持続させることができる。具体的には、当該ヒアルロン酸の0.1%水溶液を皮膚に塗布したときの皮膚水分量と比較して、当該ヒアルロン酸と本発明に係るヒアルロン酸組成物とを混合した混合物の0.1%水溶液を皮膚に塗布したときの皮膚水分量が高くなる。平均分子量が100,000超のヒアルロン酸と、本発明に係るヒアルロン酸組成物における低分子ヒアルロン酸および/またはその塩とカチオン化ヒアルロン酸および/またはその塩の合計含有量との配合比は特に限定されないが、保湿効果を持続させる点から、質量比で5:95〜80:20、好ましくは10:90〜70:30が好ましい。 The external preparation for skin according to this embodiment preferably contains hyaluronic acid having an average molecular weight of more than 100,000 and / or a salt thereof. Hyaluronic acid having an average molecular weight of more than 100,000 has a moisturizing function but does not have a sufficient moisturizing effect. By adding the hyaluronic acid composition according to the present invention to a composition containing hyaluronic acid having an average molecular weight of more than 100,000, the moisturizing function of the hyaluronic acid can be enhanced and the moisturizing effect can be maintained. Specifically, 0.1% of the mixture of the hyaluronic acid and the hyaluronic acid composition according to the present invention is compared with the amount of skin moisture when the 0.1% aqueous solution of hyaluronic acid is applied to the skin. When the aqueous solution is applied to the skin, the amount of moisture in the skin increases. The blending ratio of hyaluronic acid having an average molecular weight of over 100,000 and the total content of low molecular weight hyaluronic acid and / or salt thereof and cationized hyaluronic acid and / or salt thereof in the hyaluronic acid composition according to the present invention is particularly Although not limited, 5:95 to 80:20, preferably 10:90 to 70:30 are preferable in terms of mass ratio from the viewpoint of maintaining the moisturizing effect.
本実施形態に係る皮膚外用剤にはさらに、以下の成分が配合されていてもよい。前記成分としては、カチオン化多糖類(例えば、カチオン化ヒドロキシエチルセルロース、カチオン化グアーガム、カチオン化澱粉、カチオン化ローカストビーンガム、カチオン化デキストラン、カチオン化キトサン、カチオン化ハチミツ等)、アニオン界面活性剤(例えば、アルキルベンゼンスルホン酸塩、ポリオキシアルキレンアルキルエーテル硫酸エステル塩、アルキル硫酸エステル塩、オレフィンスルホン酸塩、脂肪酸塩、ジアルキルスルホコハク酸塩等)、非イオン界面活性剤(例えば、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油誘導体等)、陽イオン界面活性剤(例えば、アルキルトリメチルアンモニウム塩、ジアルキルジメチルアンモニウム塩、アルキルピリジニウム塩、塩化ステアリルトリメチルアンモニウム等)、両性界面活性剤(例えば、アルキルベタイン、アルキルアミドプロピルベタイン、イミダゾリニウムベタイン、卵黄レシチン、大豆レシチン等)、油分(例えば、シリコーン、シリコーン誘導体、流動パラフィン、スクワラン、ミツロウ、カルナバロウ、オリーブ油、アボガド油、ツバキ油、ホホバ油、馬油等)、保湿剤(例えば、ヒアルロン酸ジメチルシラノール、セラミド、ラウロイルグルタミン酸ジフィトステリルオクチルドデシル、フィトグリコーゲン、加水分解卵殻膜、トレハロース、グリセリン、アテロコラーゲン、ソルビトール、マルチトール、1,3−ブチレングリコール等)、高級脂肪酸(例えば、ラウリン酸、ベヘニン酸、パルミチン酸、ステアリン酸、イソステアリン酸、オレイン酸等)、高級アルコール(例えば、セチルアルコール、ステアリルアルコール、ベヘニルアルコール、イソステアリルアルコール、バチルアルコール等)、多価アルコール(例えば、グリセリン、ジグリセリン、1,3−プロパンジオール、プロピレングリコール、ポリエチレングリコール、ペンチレングリコール、アルカンジオール等)、増粘剤(例えば、セルロースエーテル、カルボキシビニルポリマー、キサンタンガム、パルミチン酸デキストリン等)、両性高分子樹脂化合物(例えば、ベタイン化ジアルキルアミノアルキルアクリレート共重合体等)、カチオン性高分子樹脂化合物(例えば、ビニルピロリドン/ジメチルアミノエチルメタクリレート共重合体カチオン化物、ポリジメチルジアリルアンモニウムハライド型カチオン性ポリマー等)、防腐剤(例えば、メチルパラベン、エチルパラベン、ブチルパラベン、プロピルパラベン、フェノキシエタノール等)、酸化防止剤(例えば、トコフェノール、BHT等)、金属封鎖剤(例えば、エデト酸塩、エチドロン酸塩等)、紫外線吸収剤(例えば、ベンゾフェノン誘導体、パラアミノ安息香酸誘導体、メトキシ桂皮酸誘導体等)、紫外線反射剤(例えば、酸化チタン、酸化亜鉛等)、タンパク質加水分解物(例えば、ケラチンペプチド、コラーゲンペプチド、大豆ペプチド、コムギペプチド、ミルクペプチド、シルクペプチド、卵白ペプチド等)、アミノ酸(例えば、アルギニン、グルタミン酸、グリシン、アラニン、ヒドロキシプロリン、システイン、セリン、L−テアニン等)、天然物エキス(クジンエキス、カジルエキス、テンチカエキス、海草エキス、ユーカリエキス、ローヤルゼリーエキス、ローズマリーエキス、ブナの木エキス等)、その他の機能性成分(コエンザイムQ10、アルブチン、ポリクオタニウム51、エラスチン、白金ナノコロイド、パルミチン酸レチノール、パンテノール、アラントイン、ジラウロイルグルタミン酸リシンナトリウム、リン酸アスコルビルマグネシウム、L−アスコルビン酸2−グルコシド、エラグ酸、コウジ酸、リノール酸、トラネキサム酸等)、リン脂質ポリマー、香料、色素が挙げられる。 The following components may be further blended in the external preparation for skin according to the present embodiment. Examples of the component include cationized polysaccharides (for example, cationized hydroxyethyl cellulose, cationized guar gum, cationized starch, cationized locust bean gum, cationized dextran, cationized chitosan, and cationized honey), anionic surfactants ( For example, alkylbenzene sulfonate, polyoxyalkylene alkyl ether sulfate, alkyl sulfate, olefin sulfonate, fatty acid salt, dialkyl sulfosuccinate, etc.), nonionic surfactant (eg, polyoxyethylene fatty acid ester, Polyoxyethylene hydrogenated castor oil derivatives, etc.), cationic surfactants (eg alkyl trimethyl ammonium salts, dialkyl dimethyl ammonium salts, alkyl pyridinium salts, stearyl trimethyl chloride) Ammonium), amphoteric surfactants (eg, alkylbetaines, alkylamidopropylbetaines, imidazolinium betaines, egg yolk lecithin, soybean lecithin, etc.), oils (eg, silicone, silicone derivatives, liquid paraffin, squalane, beeswax, carnauba wax, Olive oil, avocado oil, camellia oil, jojoba oil, horse oil, etc.), moisturizer (eg, dimethylsilanol hyaluronate, ceramide, lauroyl glutamate diphytosteryl octyldodecyl, phytoglycogen, hydrolyzed egg shell membrane, trehalose, glycerin, atelocollagen Sorbitol, maltitol, 1,3-butylene glycol, etc.), higher fatty acids (eg, lauric acid, behenic acid, palmitic acid, stearic acid, isostearic acid, oleic acid, etc.), higher Lucol (eg, cetyl alcohol, stearyl alcohol, behenyl alcohol, isostearyl alcohol, batyl alcohol, etc.), polyhydric alcohol (eg, glycerin, diglycerin, 1,3-propanediol, propylene glycol, polyethylene glycol, pentylene glycol, alkane) Diol, etc.), thickener (eg, cellulose ether, carboxyvinyl polymer, xanthan gum, dextrin palmitate, etc.), amphoteric polymer resin compound (eg, betainated dialkylaminoalkyl acrylate copolymer), cationic polymer resin Compound (for example, cationized vinylpyrrolidone / dimethylaminoethyl methacrylate copolymer, polydimethyldiallylammonium halide type cationic polymer), Preservatives (for example, methylparaben, ethylparaben, butylparaben, propylparaben, phenoxyethanol, etc.), antioxidants (for example, tocophenol, BHT, etc.), sequestering agents (for example, edetate, etidronate, etc.), ultraviolet rays Absorbents (eg, benzophenone derivatives, paraaminobenzoic acid derivatives, methoxycinnamic acid derivatives, etc.), ultraviolet reflectors (eg, titanium oxide, zinc oxide, etc.), protein hydrolysates (eg, keratin peptides, collagen peptides, soybean peptides, Wheat peptides, milk peptides, silk peptides, egg white peptides, etc.), amino acids (eg, arginine, glutamic acid, glycine, alanine, hydroxyproline, cysteine, serine, L-theanine, etc.), natural product extracts (kudin extract, kazil extract, te Chica extract, seaweed extract, eucalyptus extract, royal jelly extract, rosemary extract, beech tree extract, etc.) and other functional ingredients (coenzyme Q10, arbutin, polyquaternium 51, elastin, platinum nanocolloid, retinol palmitate, panthenol, allantoin) , Dilauroyl glutamic acid ricin sodium, ascorbyl magnesium phosphate, L-ascorbic acid 2-glucoside, ellagic acid, kojic acid, linoleic acid, tranexamic acid, etc.), phospholipid polymers, fragrances, and pigments.
3.皮膚水分量
本発明において、皮膚の水分量は高周波コンダクタンス変換方式の水分測定器により測定できる。皮膚表皮角質の水分含有率とコンダクタンスは高い相関性をもっていることが知られており、一般的に水分含有率が高いと表皮角質のコンダクタンスは大きくなる。
3. Skin Moisture Content In the present invention, the skin moisture content can be measured by a high-frequency conductance conversion type moisture meter. It is known that the moisture content and conductance of the skin epidermis are highly correlated, and generally the conductance of the epidermis becomes large when the moisture content is high.
4.実施例
以下、実施例によって本発明をさらに詳細に説明するが、本発明は実施例に限定されない。
4). Examples Hereinafter, the present invention will be described in more detail by way of examples. However, the present invention is not limited to the examples.
4.1.実施例1
4.1.1.ヒアルロン酸組成物の製造
(低分子ヒアルロン酸の調製)
本実施例では、原料として、鶏冠より抽出、精製したヒアルロン酸ナトリウム微粉末を準備した。この原料ヒアルロン酸ナトリウムの平均分子量は約210万、純度97%であった。
4.1. Example 1
4.1.1. Production of hyaluronic acid composition (Preparation of low molecular weight hyaluronic acid)
In this example, a sodium hyaluronate fine powder extracted and purified from a chicken crown was prepared as a raw material. This raw material sodium hyaluronate had an average molecular weight of about 2.1 million and a purity of 97%.
まず、300mL容ビーカーに、0.5%硫酸含有80%含水アセトン(酸性含水媒体)110Lを満たし、攪拌しながら液温が60℃となるよう加熱した。ここで、80%含水アセトンは、アセトンを80(W/W)%含有し、水を20(W/W)%含有するものであり、0.5%硫酸含有80%含水アセトンは、硫酸を0.5(W/W)%含有し、80%含水アセトンを99.5(W/W)%含有するものである。60℃に達温後、攪拌しながら、準備した原料ヒアルロン酸ナトリウム微粉末6gをタンクに投入した。硫酸含有含水アセトンの温度を60℃に維持するように加熱を行いながら、原料ヒアルロン酸ナトリウム微粉末が分散状態となるように攪拌した。 First, a 300 mL beaker was filled with 110 L of 80% water-containing acetone (acidic water-containing medium) containing 0.5% sulfuric acid and heated so that the liquid temperature became 60 ° C. while stirring. Here, 80% water-containing acetone contains 80 (W / W)% acetone and 20 (W / W)% water, and 80% water-containing acetone containing 0.5% sulfuric acid contains sulfuric acid. It contains 0.5 (W / W)% and contains 99.5 (W / W)% 80% water-containing acetone. After the temperature reached 60 ° C., 6 g of the prepared raw material sodium hyaluronate fine powder was charged into the tank while stirring. While heating so as to maintain the temperature of the sulfuric acid-containing aqueous acetone at 60 ° C., the raw material sodium hyaluronate fine powder was stirred so as to be in a dispersed state.
次に、15分間攪拌してから静置した後、上澄みの硫酸含有含水アセトンをデカンテーションにより除去することにより、沈殿物を得た。得られた沈殿物に、予め60℃に加熱した0.5%硫酸含有80%含水アセトン110mLを加え、同様に60℃に加熱しながら攪拌を15分間行い、この操作を合計3回繰り返した。 Next, after stirring for 15 minutes and allowing to stand, the supernatant sulfuric acid-containing water-containing acetone was removed by decantation to obtain a precipitate. To the resulting precipitate, 110 mL of 0.5% sulfuric acid-containing 80% water-containing acetone previously heated to 60 ° C. was added, and similarly stirred for 15 minutes while heating to 60 ° C. This operation was repeated a total of 3 times.
次いで、硫酸含有含水アセトンを除去した後に得られた沈殿物に80%含水アセトン110mLを加え、硫酸除去の目的で15分間の攪拌を行なった。硫酸の残留がなくなるまでこの操作を繰り返した。 Next, 110 mL of 80% aqueous acetone was added to the precipitate obtained after removing the sulfuric acid-containing aqueous acetone, and the mixture was stirred for 15 minutes for the purpose of removing sulfuric acid. This operation was repeated until no sulfuric acid remained.
さらに、含水アセトンをデカンテーションにより除去して残留物を得た。この残留物について遠心分離処理を行うことにより含水アセトンをさらに除去した後、真空乾燥機を用いて室温で6時間脱溶媒を行った。 Furthermore, water-containing acetone was removed by decantation to obtain a residue. The residue was further centrifuged to remove water-containing acetone, and then the solvent was removed using a vacuum dryer at room temperature for 6 hours.
以上の工程により、白色微粉末の低分子ヒアルロン酸5.3g(収率約88%)を得た。この低分子ヒアルロン酸は、ウベローデ粘度計を用いて測定された1%水溶液の動粘度が1.5mm2/sであり、極限粘度より換算した分子量が9,000であった。 Through the above steps, 5.3 g (yield: about 88%) of low molecular weight hyaluronic acid as white fine powder was obtained. This low-molecular hyaluronic acid had a kinematic viscosity of 1 mm aqueous solution measured using an Ubbelohde viscometer of 1.5 mm 2 / s, and a molecular weight calculated from the intrinsic viscosity was 9,000.
(カチオン化ヒアルロン酸の調製)
1L容ビーカーに、ヒアルロン酸ナトリウム(キユーピー株式会社製、平均分子量200万)20g、5%水酸化ナトリウム20mL、80%含水エタノール180mL、およびグリシジルトリメチルアンモニウムクロリド(GTA(有効成分約80%、水分約20%))30mLを添加し、撹拌子を用いて撹拌しながら、40℃で1時間反応させた。
次に、デカンテーションにより液を除去して、固形物(カチオン化ヒアルロン酸を含む)を得た。
(Preparation of cationized hyaluronic acid)
In a 1 L beaker, 20 g of sodium hyaluronate (manufactured by Kewpie Corporation, average molecular weight 2 million), 20 mL of 5% sodium hydroxide, 180 mL of 80% water-containing ethanol, and glycidyltrimethylammonium chloride (GTA (active ingredient about 80%, moisture about 20%)) 30 mL was added and reacted for 1 hour at 40 ° C. with stirring using a stir bar.
Next, the liquid was removed by decantation to obtain a solid (including cationized hyaluronic acid).
次いで、食塩水400mLを加え、固形物を溶解させた。固形物が完全に溶解したことを確認した後、エタノール600mLを添加して、カチオン化ヒアルロン酸を沈殿させた。デカンテーションにより液を除去した後、80%含水エタノール500mLを添加して15分間撹拌し、さらに、含水エタノールをデカンテーションにより除去して沈殿物を得た。この操作を3回繰り返し、沈殿物に残存するカチオン化剤(GTA)および食塩を除去した。 Next, 400 mL of brine was added to dissolve the solid. After confirming that the solid was completely dissolved, 600 mL of ethanol was added to precipitate cationized hyaluronic acid. After removing the liquid by decantation, 500 mL of 80% aqueous ethanol was added and stirred for 15 minutes, and the aqueous ethanol was then removed by decantation to obtain a precipitate. This operation was repeated three times to remove the cationizing agent (GTA) and sodium chloride remaining in the precipitate.
次いで、遠心分離処理を行うことにより含水エタノールをさらに除去した後、真空乾燥機を用いて、60℃にて減圧で5時間加熱乾燥を行った。
これにより、白色粉末のカチオン化ヒアルロン酸20.5gを得た。このカチオン化ヒアルロン酸の窒素含有率を測定し、上述の計算式によって求めたカチオン化度は0.27であった。
Next, the water-containing ethanol was further removed by performing a centrifugal separation treatment, followed by heat drying at 60 ° C. under reduced pressure for 5 hours using a vacuum dryer.
As a result, 20.5 g of cationized hyaluronic acid as a white powder was obtained. The nitrogen content of this cationized hyaluronic acid was measured, and the degree of cationization determined by the above formula was 0.27.
(ヒアルロン酸組成物の製造)
上記の方法で得られた低分子ヒアルロン酸とカチオン化ヒアルロン酸とを含有割合が質量比で50:50となるように粉体混合を行い、本発明のヒアルロン酸組成物を得た。
(Production of hyaluronic acid composition)
The low molecular hyaluronic acid obtained by the above method and cationized hyaluronic acid were mixed by powder so that the content ratio was 50:50 by mass ratio to obtain the hyaluronic acid composition of the present invention.
4.1.2.試験例1
本発明のヒアルロン酸組成物をヒトに経皮投与して、保湿効果の持続性の評価を行った。より具体的には、本発明のヒアルロン酸組成物を被験者の上腕部に塗布し、24時間後経過後の皮膚の水分量を測定し、対照(ヒアルロン酸単独)との比較を行った。
4.1.2. Test example 1
The hyaluronic acid composition of the present invention was transdermally administered to humans, and the durability of the moisturizing effect was evaluated. More specifically, the hyaluronic acid composition of the present invention was applied to the upper arm of the subject, the moisture content of the skin after 24 hours was measured, and compared with the control (hyaluronic acid alone).
4.1.3.使用した試料
試験液1:実施例1で得られたヒアルロン酸組成物の1%水溶液
試験液2:分子量120万のヒアルロン酸(キユーピー株式会社製)の1%水溶液
試験液3:アセチル化ヒアルロン酸の1%水溶液
なお、上記試験液1は沈殿物を生じることなく水に溶解していた。
4.1.3. Used sample test solution 1: 1% aqueous solution test solution of hyaluronic acid composition obtained in Example 1 2: 1% aqueous solution test solution of hyaluronic acid with molecular weight of 1,200,000 (manufactured by QP Corporation) 3: Acetylated hyaluronic acid In addition, the said test liquid 1 was melt | dissolving in water, without producing a precipitate.
4.1.4.測定機器
水分量測定器:商品名「SKICON−200」,I.B.S.Co.,LTD製
試料塗布前の皮膚水分量測定値を0としたときの各時間における皮膚水分量の変化量を算出した。
4.1.4. Measuring equipment Moisture content measuring device: trade name “SKICON-200”, I.D. B. S. Co. The amount of change in the amount of skin moisture at each time when the measured value of the amount of skin moisture before application of the sample was 0 was calculated.
被験者(成人10名:男性5名、女性5名)の右腕前腕部を石鹸で洗浄後、2cm×2cmの試料塗布エリアを設定し、室温20〜25℃、湿度45〜55%の環境下で20分間安静後、試料塗布前の皮膚水分量を測定した。その後、試験液1〜3をそれぞれ20μLずつ均一に塗布し、塗布部位の皮膚の水分量を水分量測定器にて測定した。水分量の測定は、塗布直前、塗布後20分、40分、120分、240分、360分、24時間経過時にそれぞれ行った。なお、測定は各エリア4回ずつ行った。
その結果を表1に示す。表1に示される数値は、皮膚水分変化量であり、塗布直前の皮膚水分量を0としたときの皮膚水分量の変化量である。また、表1に示される数値は、被験者10名の平均の数値である。また、各時間においてFisherのPLSD法による多重比較検定を行い、危険率p<0.05で有意差ありと判定した。
After washing the forearm of the right arm of subjects (10 adults: 5 men, 5 women) with soap, set a sample application area of 2 cm x 2 cm, in an environment of room temperature 20-25 ° C and humidity 45-55% After resting for 20 minutes, the skin moisture content before the sample application was measured. Then, each 20 microliters of test solutions 1-3 were apply | coated uniformly, and the moisture content of the skin of an application | coating site | part was measured with the moisture content measuring device. The moisture content was measured immediately before coating, 20 minutes, 40 minutes, 120 minutes, 240 minutes, 360 minutes, and 24 hours after coating. The measurement was performed four times for each area.
The results are shown in Table 1. The numerical values shown in Table 1 are the amount of change in skin moisture, and the amount of change in skin moisture when the amount of skin moisture immediately before application is zero. Moreover, the numerical value shown in Table 1 is an average numerical value of 10 subjects. In addition, a multiple comparison test by Fisher's PLSD method was performed at each time, and it was determined that there was a significant difference at a risk rate p <0.05.
表1によれば、試験液1を塗布した場合、試験液2、3を塗布した場合と比較して、皮膚の水分量を多く保持できることが確認された。 According to Table 1, it was confirmed that when the test solution 1 was applied, the amount of moisture in the skin could be retained more than when the test solutions 2 and 3 were applied.
4.2.実施例2
分子量180万のヒアルロン酸を以下の割合になるように実施例1で得られたヒアルロン酸組成物と混合し、実施例2を得た。
4.2. Example 2
Example 2 was obtained by mixing hyaluronic acid having a molecular weight of 1.8 million with the hyaluronic acid composition obtained in Example 1 so as to have the following ratio.
実施例2のヒアルロン酸組成物
実施例1のヒアルロン酸組成物 50部
分子量180万のヒアルロン酸 50部
Hyaluronic acid composition of Example 2 50 parts of hyaluronic acid composition of Example 1 50 parts of hyaluronic acid with a molecular weight of 1.8 million
4.3.実施例3
分子量180万のヒアルロン酸を以下の割合になるように実施例1で得られたヒアルロン酸組成物と混合し、実施例3を得た。
4.3. Example 3
Example 3 was obtained by mixing hyaluronic acid having a molecular weight of 1.8 million with the hyaluronic acid composition obtained in Example 1 so as to have the following ratio.
実施例3のヒアルロン酸組成物
実施例1のヒアルロン酸組成物 60部
分子量180万のヒアルロン酸 40部
Hyaluronic acid composition of Example 3 Hyaluronic acid composition of Example 1 60 parts Hyaluronic acid with a molecular weight of 1.8 million 40 parts
4.4.試験例2
前記試験例1と同様の方法で、本発明のヒアルロン酸組成物をヒトに経皮投与して、保湿効果の持続性の評価を行った。
4.4. Test example 2
In the same manner as in Test Example 1, the hyaluronic acid composition of the present invention was transdermally administered to humans, and the durability of the moisturizing effect was evaluated.
4.4.1.使用した試料
試験液4:実施例2で得られたヒアルロン酸組成物の0.1%水溶液
試験液5:実施例3で得られたヒアルロン酸組成物の0.1%水溶液
試験液6:分子量120万のヒアルロン酸(キユーピー株式会社製)の0.1%水溶液
なお、上記試験液4および5は沈殿物を生じることなく水に溶解していた。
4.4.1. Sample test solution 4: 0.1% aqueous solution test solution of hyaluronic acid composition obtained in Example 2 5: 0.1% aqueous solution test solution of hyaluronic acid composition obtained in Example 3 6: Molecular weight 1,200,000 0.1% aqueous solution of hyaluronic acid (manufactured by QP Corporation) The test solutions 4 and 5 were dissolved in water without causing precipitation.
4.4.2.測定機器
水分量測定器:商品名「SKICON−200」,I.B.S.Co.,LTD製
4.4.2. Measuring equipment Moisture content measuring device: trade name “SKICON-200”, I.D. B. S. Co. Made by LTD
被験者(成人14名:男性9名、女性5名)の左腕前腕部を石鹸で洗浄後、2cm×2cmの試料塗布エリアを設定し、室温20〜25℃、湿度45〜55%の環境下で20分間安静後、試料塗布前の皮膚水分量を測定した。その後、試験液4〜6をそれぞれ20μLずつ均一に塗布し、塗布部位の皮膚の水分量を水分量測定器にて測定した。水分量の測定は、塗布直前、塗布後10分、20分、40分、60分、120分経過時にそれぞれ行った。なお、測定は各エリア8回ずつ行い、最大値、最小値を除いた6回の平均を採用した。
その結果を表2に示す。表2に示される数値は、皮膚水分変化量であり、塗布直前の皮膚水分量を0としたときの皮膚水分量の変化量である。また、表2に示される数値は、被験者14名の平均の数値である。また、各時間において塗布前との比較はDunnettの多重比較検定、群間の比較はTukeyの多重比較検定を行い、危険率p<0.05で有意差ありと判定した。
After washing the left arm forearm of subjects (14 adults: 9 males and 5 females) with soap, a 2 cm x 2 cm sample application area is set, and the room temperature is 20-25 ° C and the humidity is 45-55%. After resting for 20 minutes, the skin moisture content before the sample application was measured. Then, each 20 microliters of test solutions 4-6 were apply | coated uniformly, and the moisture content of the skin of the application | coating site | part was measured with the moisture content measuring device. The moisture content was measured immediately before application, and at the time when 10 minutes, 20 minutes, 40 minutes, 60 minutes, and 120 minutes had elapsed after application. The measurement was performed 8 times for each area, and an average of 6 times excluding the maximum value and the minimum value was adopted.
The results are shown in Table 2. The numerical values shown in Table 2 are the amount of change in skin moisture, and the amount of change in skin moisture when the amount of skin moisture immediately before application is zero. Moreover, the numerical value shown in Table 2 is an average numerical value of 14 subjects. At each time, Dunnett's multiple comparison test was performed for comparison with the time before application, and Tukey's multiple comparison test was performed for comparison between groups, and it was determined that there was a significant difference at a risk rate p <0.05.
表2によれば、試験液4、5を塗布した場合、試験液6を塗布した場合と比較して、皮膚の水分量を多く保持できることが確認された。 According to Table 2, it was confirmed that when the test solutions 4 and 5 were applied, the amount of moisture in the skin could be retained more than when the test solution 6 was applied.
4.5.実施例4
本実施例では、以下に記す処方にて、実施例1で得られたヒアルロン酸組成物を配合した皮膚外用剤として、化粧水を調製した。
ヒアルロン酸組成物(実施例1) 0.2%
アセチル化ヒアルロン酸 0.1%
コンドロイチン硫酸 0.1%
コラーゲンペプチド 0.1%
1,3−ブチレングリコール 5.0%
グリセリン 3.0%
イソステアリルアルコール 0.1%
酢酸トコフェロール 0.1%
POE(20)ソルビタンモノラウリル酸エステル 0.5%
POE(15)ラウリルアルコールエーテル 0.5%
ピロリドンカルボン酸亜鉛 0.1%
エチルパラベン 0.1%
メチルパラベン 0.15%
エタノール 5.0%
香料 適量
精製水 残量
4.5. Example 4
In this example, lotion was prepared as a skin external preparation formulated with the hyaluronic acid composition obtained in Example 1 according to the formulation described below.
Hyaluronic acid composition (Example 1) 0.2%
Acetylated hyaluronic acid 0.1%
Chondroitin sulfate 0.1%
Collagen peptide 0.1%
1,3-butylene glycol 5.0%
Glycerol 3.0%
Isostearyl alcohol 0.1%
Tocopherol acetate 0.1%
POE (20) sorbitan monolaurate 0.5%
POE (15) lauryl alcohol ether 0.5%
Zinc pyrrolidonecarboxylate 0.1%
Ethylparaben 0.1%
Methylparaben 0.15%
Ethanol 5.0%
Perfume Appropriate amount Purified water Remaining
4.6.実施例5
本実施例では、以下に記す処方にて、実施例1で得られたヒアルロン酸組成物を配合した皮膚外用剤として、乳液を調製した。
ヒアルロン酸組成物(実施例1) 0.3%
ペンチレングリコール 5.0%
グリセリン 3.0%
スクワラン 5.0%
ステアリン酸 0.5%
ステアリルアルコール 2.0%
ワセリン 4.0%
ステアリン酸ソルビタン 1.0%
POE(10)モノステアリン酸エステル 1.0%
カルボキシビニルポリマー 0.5%
ポリクオタニウム−51 0.1%
メチルパラベン 0.15%
プロピルパラベン 0.1%
水酸化カリウム 0.1%
BHT 0.02%
EDTA−2ナトリウム 0.02%
香料 適量
精製水 残量
4.6. Example 5
In this example, an emulsion was prepared as an external preparation for skin containing the hyaluronic acid composition obtained in Example 1 according to the formulation described below.
Hyaluronic acid composition (Example 1) 0.3%
Pentylene glycol 5.0%
Glycerol 3.0%
Squalane 5.0%
Stearic acid 0.5%
Stearyl alcohol 2.0%
Vaseline 4.0%
Sorbitan stearate 1.0%
POE (10) monostearate 1.0%
Carboxy vinyl polymer 0.5%
Polyquaternium-51 0.1%
Methylparaben 0.15%
Propylparaben 0.1%
Potassium hydroxide 0.1%
BHT 0.02%
EDTA-2 sodium 0.02%
Perfume Appropriate amount Purified water Remaining
4.7.実施例6
本実施例では、以下に記す処方にて、実施例1で得られたヒアルロン酸組成物を配合した皮膚外用剤として、クリーム(エモリエントクリーム)を調製した。
ヒアルロン酸組成物(実施例1) 0.5%
ポリエチレングリコール 4.0%
1,3−プロパンジオール 6.0%
スクワラン 11.0%
ジメチコン 1.0%
セタノール 6.0%
ステアリン酸 2.0%
水添ココグリセリル 4.0%
トリカプリリン 8.0%
モノステアリン酸グリセリン 3.0%
POE(20)セチルアルコールエーテル 2.0%
コエンザイムQ10 0.03%
セラミド 0.1%
ジラウロイルグルタミン酸リシンナトリウム 0.1%
EDTA−2ナトリウム 0.02%
プロピルパラベン 0.1%
メチルパラベン 0.15%
香料 適量
精製水 残量
4.7. Example 6
In this example, a cream (emollient cream) was prepared as a skin external preparation containing the hyaluronic acid composition obtained in Example 1 according to the formulation described below.
Hyaluronic acid composition (Example 1) 0.5%
Polyethylene glycol 4.0%
1,3-propanediol 6.0%
Squalane 11.0%
Dimethicone 1.0%
Cetanol 6.0%
Stearic acid 2.0%
Hydrogenated cocoglyceryl 4.0%
Tricaprylin 8.0%
Glycerol monostearate 3.0%
POE (20) cetyl alcohol ether 2.0%
Coenzyme Q10 0.03%
Ceramide 0.1%
Dilauroyl glutamate ricin sodium 0.1%
EDTA-2 sodium 0.02%
Propylparaben 0.1%
Methylparaben 0.15%
Perfume Appropriate amount Purified water Remaining
4.8.実施例7
本実施例では、以下に記す処方にて、実施例1で得られたヒアルロン酸組成物を配合した皮膚外用剤として、美容液(美白保湿エッセンス)を調製した。
ヒアルロン酸組成物(実施例1) 0.8%
1,3−ブチレングリコール 5.0%
グリセリン 1.5%
POEソルビタンモノステアリン酸エステル 1.0%
ソルビタンモノステアリン酸エステル 0.5%
キサンタンガム 0.2%
アルギン酸ナトリウム 0.2%
カルボキシビニルポリマー 0.2%
水酸化カリウム 0.1%
オリーブ油 0.2%
トコフェロール 0.1%
EDTA−2ナトリウム 0.02%
アルギニン 0.15%
グリチルリチン酸ジカリウム 0.05%
アルブチン 0.2%
パルミチン酸レチノール 0.2%
クジンエキス 0.2%
海藻エキス 0.2%
トラネキサム酸 0.1%
エラスチン 0.1%
コラーゲン 0.1%
リン酸アスコルビン酸マグネシウム 0.1%
クエン酸ナトリウム 1.0%
クエン酸 0.1%
プロピルパラベン 0.1%
メチルパラベン 0.15%
香料 適量
精製水 残量
4.8. Example 7
In this example, a cosmetic liquid (whitening moisturizing essence) was prepared as an external preparation for skin containing the hyaluronic acid composition obtained in Example 1 according to the formulation described below.
Hyaluronic acid composition (Example 1) 0.8%
1,3-butylene glycol 5.0%
Glycerin 1.5%
POE sorbitan monostearate 1.0%
Sorbitan monostearate 0.5%
Xanthan gum 0.2%
Sodium alginate 0.2%
Carboxyvinyl polymer 0.2%
Potassium hydroxide 0.1%
Olive oil 0.2%
Tocopherol 0.1%
EDTA-2 sodium 0.02%
Arginine 0.15%
Dipotassium glycyrrhizinate 0.05%
Arbutin 0.2%
Retinol palmitate 0.2%
Cousin extract 0.2%
Seaweed extract 0.2%
Tranexamic acid 0.1%
Elastin 0.1%
Collagen 0.1%
Magnesium phosphate ascorbate 0.1%
Sodium citrate 1.0%
Citric acid 0.1%
Propylparaben 0.1%
Methylparaben 0.15%
Perfume Appropriate amount Purified water Remaining
4.9.実施例8
本実施例では、以下に記す処方にて、実施例1で得られたヒアルロン酸組成物を配合した皮膚外用剤として、美容液パック(ペースト状ピールオフタイプを調製した。
ヒアルロン酸組成物(実施例1) 0.5%
ポリ酢酸ビニルエマルジョン 17.0%
ポリビニルアルコール 11.0%
ソルビトール 5.0%
ポリエチレングリコール400 5.0%
スクワラン 2.5%
POEソルビタンモノステアリン酸エステル 1.0%
酸化チタン 4.0%
タルク 8.0%
エタノール 8.0%
メチルパラベン 0.15%
香料 適量
精製水 残量
4.9. Example 8
In this example, a cosmetic liquid pack (paste peel-off type) was prepared as a skin external preparation formulated with the hyaluronic acid composition obtained in Example 1 according to the formulation described below.
Hyaluronic acid composition (Example 1) 0.5%
Polyvinyl acetate emulsion 17.0%
Polyvinyl alcohol 11.0%
Sorbitol 5.0%
Polyethylene glycol 400 5.0%
Squalane 2.5%
POE sorbitan monostearate 1.0%
Titanium oxide 4.0%
Talc 8.0%
Ethanol 8.0%
Methylparaben 0.15%
Perfume Appropriate amount Purified water Remaining
4.10.実施例9
本実施例では、以下に記す処方にて、実施例1で得られたヒアルロン酸組成物を配合した皮膚外用剤として、洗顔料(クレンジングフォーム)を調製した。
ヒアルロン酸組成物(実施例1) 0.2%
グリセリン 10.0%
ポリエチレングリコール400 15.0%
ジプロピレングリコール 10.0%
ラウロイルグルタミン酸ナトリウム 20.0%
POE(2)モノステアリン酸エステル 5.0%
パーム脂肪酸グルタミン酸ナトリウム 8.0%
アルキルベタイン 2.0%
EDTA−2ナトリウム 0.02%
プロピルパラベン 0.1%
メチルパラベン 0.15%
香料 適量
精製水 残量
4.10. Example 9
In this example, a face wash (cleansing foam) was prepared as a skin external preparation formulated with the hyaluronic acid composition obtained in Example 1 according to the formulation described below.
Hyaluronic acid composition (Example 1) 0.2%
Glycerin 10.0%
Polyethylene glycol 400 15.0%
Dipropylene glycol 10.0%
Sodium lauroyl glutamate 20.0%
POE (2) monostearate 5.0%
Palm fatty acid sodium glutamate 8.0%
Alkyl betaine 2.0%
EDTA-2 sodium 0.02%
Propylparaben 0.1%
Methylparaben 0.15%
Perfume Appropriate amount Purified water Remaining
4.11.実施例10
本実施例では、以下に記す処方にて、実施例1で得られたヒアルロン酸組成物を配合した皮膚外用剤として、サンスクリーン(乳液)を調製した。
ヒアルロン酸組成物(実施例1) 0.2%
1,3−ブチレングリコール 3.0%
ジプロピレングリコール 3.0%
シクロメチコン 5.0%
ジメチコン 5.0%
セタノール 1.0%
ワセリン 1.0%
メトキシケイヒ酸オクチル 5.0%
酸化チタン 2.0%
酸化亜鉛 2.0%
ステアリン酸ソルビタン 1.0%
POE(20)ソルビタンモノステアリン酸エステル 1.0%
フェノキシエタノール 0.8%
メチルパラベン 0.1%
香料 適量
精製水 残量
4.11. Example 10
In this example, a sunscreen (milky lotion) was prepared as an external preparation for skin containing the hyaluronic acid composition obtained in Example 1 according to the formulation described below.
Hyaluronic acid composition (Example 1) 0.2%
1,3-butylene glycol 3.0%
Dipropylene glycol 3.0%
Cyclomethicone 5.0%
Dimethicone 5.0%
Cetanol 1.0%
Vaseline 1.0%
Octyl methoxycinnamate 5.0%
Titanium oxide 2.0%
Zinc oxide 2.0%
Sorbitan stearate 1.0%
POE (20) sorbitan monostearate 1.0%
Phenoxyethanol 0.8%
Methylparaben 0.1%
Perfume appropriate amount Purified water remaining
4.12.実施例11
本実施例では、以下に記す処方にて、実施例1で得られたヒアルロン酸組成物を配合した皮膚外用剤として、リップクリームを調製した。
ヒアルロン酸組成物(実施例1) 0.1%
マイクロクリスタリンワックス 1.5%
セレシン 12.0%
スクワラン 10.0%
デカメチルテトラシロキサン 10.0%
リンゴ酸ジイソステアリル 5.0%
キャンデリラロウ 2.0%
ワセリン 8.0%
ヒドロキシステアリン酸グリセリル 2.0%
メントール 0.05%
流動パラフィン 1.0%
酢酸トコフェロール 0.1%
トコフェロール 0.05%
プロピルパラベン 0.1%
香料 適量
精製水 残量
4.12. Example 11
In this example, a lip balm was prepared as a skin external preparation containing the hyaluronic acid composition obtained in Example 1 according to the formulation described below.
Hyaluronic acid composition (Example 1) 0.1%
Microcrystalline wax 1.5%
Ceresin 12.0%
Squalane 10.0%
Decamethyltetrasiloxane 10.0%
Diisostearyl malate 5.0%
Candelilla wax 2.0%
Vaseline 8.0%
Glyceryl hydroxystearate 2.0%
Menthol 0.05%
Liquid paraffin 1.0%
Tocopherol acetate 0.1%
Tocopherol 0.05%
Propylparaben 0.1%
Perfume Appropriate amount Purified water Remaining
4.13.実施例12
本実施例では、以下に記す処方にて、実施例1で得られたヒアルロン酸組成物を配合した皮膚外用剤として、シャンプーを調製した。
ヒアルロン酸組成物(実施例1) 0.2%
POE(20)ラウリルエーテル硫酸ナトリウム 11.0%
ラウロイルアスパラギン酸ナトリウム 10.0%
ヤシ油脂肪酸アミドプロピルベタイン 4.0%
ヤシ油脂肪酸モノエタノールアミド 2.0%
EDTA−2ナトリウム 0.1%
安息香酸ナトリウム 0.2%
フェノキシエタノール 0.8%
メチルパラベン 0.1%
香料 適量
精製水 残量
4.13. Example 12
In this example, a shampoo was prepared as a skin external preparation formulated with the hyaluronic acid composition obtained in Example 1 according to the formulation described below.
Hyaluronic acid composition (Example 1) 0.2%
POE (20) sodium lauryl ether sulfate 11.0%
Lauroyl sodium aspartate 10.0%
Coconut oil fatty acid amidopropyl betaine 4.0%
Coconut oil fatty acid monoethanolamide 2.0%
EDTA-2 sodium 0.1%
Sodium benzoate 0.2%
Phenoxyethanol 0.8%
Methylparaben 0.1%
Perfume appropriate amount Purified water remaining
4.14.実施例13
本実施例では、以下に記す処方にて、実施例1で得られたヒアルロン酸組成物を配合した皮膚外用剤として、ヘアコンディショナーを調製した。
ヒアルロン酸組成物(実施例1) 0.3%
ステアリルアルコール 4.0%
セタノール 1.5%
ヒドロキシエチルウレア 1.0%
アミノプロピルジメチコン 1.5%
ジメチコン 0.5%
加水分解シルク 1.0%
1,3−ブチレングリコール 1.0%
グリセリン 3.0%
2−エチルヘキサン酸セチル 2.0%
ミリスチン酸イソセチル 0.4%
L−アルギニン 0.1%
トレハロース 0.1%
ソルビトール 0.1%
ケラチンペプチド 0.1%
POE(4)ステアリルエーテル 1.0%
ステアリン酸ジメチルアミノプロピルアミド 3.0%
塩化ジステアリルジメチルアンモニウム 0.2%
安息香酸ナトリウム 0.3%
フェノキシエタノール 0.8%
メチルパラベン 0.1%
香料 適量
精製水 残量
4.14. Example 13
In this example, a hair conditioner was prepared as a skin external preparation formulated with the hyaluronic acid composition obtained in Example 1 according to the formulation described below.
Hyaluronic acid composition (Example 1) 0.3%
Stearyl alcohol 4.0%
Cetanol 1.5%
Hydroxyethyl urea 1.0%
Aminopropyl dimethicone 1.5%
Dimethicone 0.5%
Hydrolyzed silk 1.0%
1,3-butylene glycol 1.0%
Glycerol 3.0%
Cetyl 2-ethylhexanoate 2.0%
Isocetyl myristate 0.4%
L-Arginine 0.1%
Trehalose 0.1%
Sorbitol 0.1%
Keratin peptide 0.1%
POE (4) stearyl ether 1.0%
Stearic acid dimethylaminopropylamide 3.0%
Distearyldimethylammonium chloride 0.2%
Sodium benzoate 0.3%
Phenoxyethanol 0.8%
Methylparaben 0.1%
Perfume Appropriate amount Purified water Remaining
Claims (5)
前記低分子ヒアルロン酸および/またはその塩と前記カチオン化ヒアルロン酸および/またはその塩をヒアルロン酸換算で合計1質量%となるように調製した前記ヒアルロン酸組成物の水溶液が、沈殿物を生じることなく水に溶解していることを特徴とするヒアルロン酸組成物。 A hyaluronic acid composition having a mass ratio of a low molecular weight hyaluronic acid and / or salt thereof having a mean molecular weight of 100,000 or less and a cationized hyaluronic acid and / or salt thereof in a mass ratio of 5:95 to 80:20, ,
An aqueous solution of the hyaluronic acid composition prepared by adding the low molecular weight hyaluronic acid and / or salt thereof and the cationized hyaluronic acid and / or salt thereof to a total amount of 1% by mass in terms of hyaluronic acid produces a precipitate. A hyaluronic acid composition characterized by being dissolved in water.
A method for increasing the amount of skin moisture using the hyaluronic acid composition according to any one of claims 1 to 3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012046575A JP2013181001A (en) | 2012-03-02 | 2012-03-02 | Hyaluronic acid composition and skin care preparation including the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012046575A JP2013181001A (en) | 2012-03-02 | 2012-03-02 | Hyaluronic acid composition and skin care preparation including the same |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2013181001A true JP2013181001A (en) | 2013-09-12 |
Family
ID=49271918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012046575A Pending JP2013181001A (en) | 2012-03-02 | 2012-03-02 | Hyaluronic acid composition and skin care preparation including the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2013181001A (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3028751A1 (en) * | 2014-11-24 | 2016-05-27 | Oreal | POWDER SYNTHETIC PHYLLOSILICATE AS A MATIFYING AGENT AND / OR HOMOGENIZING APPLICATION |
JP2016098222A (en) * | 2014-11-26 | 2016-05-30 | 小林製薬株式会社 | External composition |
JP2016098223A (en) * | 2014-11-26 | 2016-05-30 | 小林製薬株式会社 | External composition |
CN105997614A (en) * | 2016-05-16 | 2016-10-12 | 刘涛 | Full-effect repair bioactive peptide skin-tendering film |
JP2017066060A (en) * | 2015-09-29 | 2017-04-06 | 小林製薬株式会社 | External composition |
JP2017186276A (en) * | 2016-04-06 | 2017-10-12 | キユーピー株式会社 | Anti-pollution agent and skin external composition for anti-pollution |
CN107375113A (en) * | 2017-08-31 | 2017-11-24 | 广西贵港市恒桥米业有限公司 | A kind of selenium-rich rice moisture retention liquid and preparation method thereof |
CN108892742A (en) * | 2018-04-18 | 2018-11-27 | 山东众山生物科技有限公司 | A kind of micromolecule hyaluronic acid purification process |
WO2019082922A1 (en) * | 2017-10-27 | 2019-05-02 | 大日精化工業株式会社 | Cosmetic molded article and method for manufacturing same |
CN109908015A (en) * | 2019-03-26 | 2019-06-21 | 山东省药学科学院 | A kind of antiallergic repairs moisture-keeping composition and its preparation method and application |
CN111557863A (en) * | 2020-05-14 | 2020-08-21 | 华熙生物科技股份有限公司 | Application of composition containing hyaluronic acid and polyalcohol in improving skin permeability of water-soluble vitamin |
KR102215559B1 (en) * | 2019-10-08 | 2021-02-15 | 주식회사 제네웰 | Preparing method of dry hyaluronic acid based composition and dry hyaluronic acid based composition |
WO2021077320A1 (en) * | 2019-10-23 | 2021-04-29 | L'oreal | Composition for caring for the skin |
CN113648238A (en) * | 2021-08-25 | 2021-11-16 | 梅晔生物医药股份有限公司 | Bath salt containing low-molecular hyaluronic acid for bath |
CN113773412A (en) * | 2021-09-18 | 2021-12-10 | 中国科学院烟台海岸带研究所 | Process for the preparation of anionic polysaccharide derivatives |
CN113768819A (en) * | 2021-09-28 | 2021-12-10 | 山东焦点福瑞达生物股份有限公司 | Preparation method of moisturizing and anti-aging cosmetic composition containing cationic hyaluronic acid |
WO2022259901A1 (en) * | 2021-06-11 | 2022-12-15 | 株式会社 資生堂 | Hyaluronate skin-penetrating cosmetic |
CN115518004A (en) * | 2022-01-13 | 2022-12-27 | 海尼达(江苏)医疗科技有限公司 | Composition for assisting in improving oral health and application thereof |
-
2012
- 2012-03-02 JP JP2012046575A patent/JP2013181001A/en active Pending
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016083387A1 (en) * | 2014-11-24 | 2016-06-02 | L'oreal | Synthetic phyllosilicate in powder form as a mattifying and/or application homogenising agent |
FR3028751A1 (en) * | 2014-11-24 | 2016-05-27 | Oreal | POWDER SYNTHETIC PHYLLOSILICATE AS A MATIFYING AGENT AND / OR HOMOGENIZING APPLICATION |
JP2016098222A (en) * | 2014-11-26 | 2016-05-30 | 小林製薬株式会社 | External composition |
JP2016098223A (en) * | 2014-11-26 | 2016-05-30 | 小林製薬株式会社 | External composition |
WO2016084708A1 (en) * | 2014-11-26 | 2016-06-02 | 小林製薬株式会社 | Composition for external use |
WO2016084709A1 (en) * | 2014-11-26 | 2016-06-02 | 小林製薬株式会社 | Composition for external use |
JP2017066060A (en) * | 2015-09-29 | 2017-04-06 | 小林製薬株式会社 | External composition |
JP2017186276A (en) * | 2016-04-06 | 2017-10-12 | キユーピー株式会社 | Anti-pollution agent and skin external composition for anti-pollution |
CN105997614A (en) * | 2016-05-16 | 2016-10-12 | 刘涛 | Full-effect repair bioactive peptide skin-tendering film |
CN107375113A (en) * | 2017-08-31 | 2017-11-24 | 广西贵港市恒桥米业有限公司 | A kind of selenium-rich rice moisture retention liquid and preparation method thereof |
WO2019082922A1 (en) * | 2017-10-27 | 2019-05-02 | 大日精化工業株式会社 | Cosmetic molded article and method for manufacturing same |
JP2019077665A (en) * | 2017-10-27 | 2019-05-23 | 大日精化工業株式会社 | Molding for cosmetic and method for producing the same |
US11458088B2 (en) | 2017-10-27 | 2022-10-04 | Dainichiseika Color & Chemicals Mfg. Co., Ltd. | Cosmetic molded article and method for manufacturing same |
CN108892742A (en) * | 2018-04-18 | 2018-11-27 | 山东众山生物科技有限公司 | A kind of micromolecule hyaluronic acid purification process |
CN109908015B (en) * | 2019-03-26 | 2021-11-12 | 山东省药学科学院 | Anti-allergy repairing and moisturizing composition and preparation method and application thereof |
CN109908015A (en) * | 2019-03-26 | 2019-06-21 | 山东省药学科学院 | A kind of antiallergic repairs moisture-keeping composition and its preparation method and application |
KR102215559B1 (en) * | 2019-10-08 | 2021-02-15 | 주식회사 제네웰 | Preparing method of dry hyaluronic acid based composition and dry hyaluronic acid based composition |
CN114585348A (en) * | 2019-10-23 | 2022-06-03 | 莱雅公司 | Composition for caring skin |
WO2021077320A1 (en) * | 2019-10-23 | 2021-04-29 | L'oreal | Composition for caring for the skin |
CN111557863A (en) * | 2020-05-14 | 2020-08-21 | 华熙生物科技股份有限公司 | Application of composition containing hyaluronic acid and polyalcohol in improving skin permeability of water-soluble vitamin |
CN111557863B (en) * | 2020-05-14 | 2023-04-18 | 华熙生物科技股份有限公司 | Application of composition containing hyaluronic acid and polyalcohol in improving skin permeability of water-soluble vitamin |
WO2022259901A1 (en) * | 2021-06-11 | 2022-12-15 | 株式会社 資生堂 | Hyaluronate skin-penetrating cosmetic |
CN113648238A (en) * | 2021-08-25 | 2021-11-16 | 梅晔生物医药股份有限公司 | Bath salt containing low-molecular hyaluronic acid for bath |
CN113773412A (en) * | 2021-09-18 | 2021-12-10 | 中国科学院烟台海岸带研究所 | Process for the preparation of anionic polysaccharide derivatives |
CN113768819A (en) * | 2021-09-28 | 2021-12-10 | 山东焦点福瑞达生物股份有限公司 | Preparation method of moisturizing and anti-aging cosmetic composition containing cationic hyaluronic acid |
CN113768819B (en) * | 2021-09-28 | 2023-05-12 | 山东焦点福瑞达生物股份有限公司 | Preparation method of moisturizing and anti-aging cosmetic composition containing cationic hyaluronic acid |
CN115518004A (en) * | 2022-01-13 | 2022-12-27 | 海尼达(江苏)医疗科技有限公司 | Composition for assisting in improving oral health and application thereof |
CN115518004B (en) * | 2022-01-13 | 2024-01-16 | 海尼达(江苏)医疗科技有限公司 | Composition for assisting in improving oral health and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2013181001A (en) | Hyaluronic acid composition and skin care preparation including the same | |
JP5852560B2 (en) | Method for producing metal hyaluronate, method for producing cosmetics containing metal hyaluronate, zinc hyaluronate and method for producing the same | |
JP5241708B2 (en) | Cationized hyaluronic acid and / or salt thereof, method for producing the same, and hair modifying agent, cuticle restorative agent, skin modifying agent and cosmetics using the same | |
JP5756246B1 (en) | Carboxymethyl group-containing modified hyaluronic acid and / or salt thereof and / or method for producing the same | |
JP4845071B2 (en) | Modified hyaluronic acid and / or salt thereof, process for producing the same and cosmetics containing the same | |
JP5143354B2 (en) | Oligomer ester and cosmetics and skin external preparations containing these | |
JP2008285421A (en) | Hair modification penetrant and cosmetic for hair using the same | |
JP2016108344A (en) | Cosmetic containing small molecular weight of cationized hyaluronic acid | |
WO2015053282A1 (en) | Crosslinked product of carboxymethyl-group-containing modified hyaluronic acid and/or salt thereof, and method for producing same | |
JP5814181B2 (en) | Skin barrier function improver | |
JP2016166133A (en) | Pack cosmetics | |
JP5734536B1 (en) | Carboxymethyl group-containing modified hyaluronic acid and / or a salt thereof and a method for producing the same | |
JP6207184B2 (en) | Cosmetics and external preparation for skin | |
JP5683410B2 (en) | Cosmetics | |
JP2016199515A (en) | Emulsion cosmetic | |
JP2014224183A (en) | Acylated carboxymethyl cellulose and cosmetic containing acylated carboxymethyl cellulose | |
JP2013023488A (en) | Oil for cosmetic, and cosmetic combining the same | |
JP2020007274A (en) | Emulsifier used for hair care or skin external preparations, and external preparation compositions thereof | |
JP2022183243A (en) | Collagen complex and method for producing cosmetic composition containing the same | |
JPH1036214A (en) | Base material for cosmetic | |
JP2023533127A (en) | Preparation and use of skin moisturizing formulation | |
JP2018070526A (en) | Cleanser composition | |
JP2010100567A (en) | External preparation for skin |